Brief: Hydration Pharmaceuticals Says Total Net Sales For October 2022 Were $925,000, Up 125%
14/11/2022 22:58
Nov 15 (Reuters) - Hydration Pharmaceuticals Co Ltd
HPC.AX :
* TOTAL NET SALES FOR OCTOBER 2022 WERE US$925,000, UP 125%
* KEY REGULATORY APPROVAL FROM HEALTH CANADA TO COMMENCE
PRODUCTION OF HYDRALYTE LIQUID PRODUCT RANGE FOR CANADIAN MARKET
Source text for Eikon: ID:nASX4xnWRZ
Further company coverage: HPC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman